SCHEMBL9890578

SCHEMBL9890578

CC(=O)Nc1cc(-c2nc(C(=O)NCc3ccccn3)c(-c3ccccc3Cl)o2)c(C)cn1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.47
ALDH1A1 P00352 3/20 0.47
CYP1A2 P05177 2/20 0.47
NPC1 O15118 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
HTT P42858 2/20 0.47
TSHR P16473 1/20 0.47
ADORA2A P29274 2/20 0.45
ADORA1 P30542 2/20 0.45
KDM4E B2RXH2 1/20 0.45
RAB9A P51151 2/20 0.43
POLB P06746 1/20 0.42
KMT2A Q03164 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PDE2A O00408 1/20 0.42
GLA P06280 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9109647 0.89 MAPT (0.43) HPGDALDH1A1NPC1HTTKDM4E
SCHEMBL9104246 0.89 HSP90AB1 (0.46) HPGDALDH1A1HTTKDM4EKMT2A
SCHEMBL9105067 0.88 ALDH1A1 (0.46) HPGDALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL9104901 0.87 GAA (0.44) ALDH1A1CYP1A2NPC1CYP3A4HTT
SCHEMBL9890577 0.86 MAPT (0.46) HPGDALDH1A1NPC1HTTTSHR
SCHEMBL9108437 0.85 PIK3C3 (0.42) ALDH1A1HTTKDM4ERAB9AKMT2A
SCHEMBL9106485 0.85 PIK3C3 (0.38) ALDH1A1NPC1HTTKDM4ERAB9A
SCHEMBL9108294 0.85 ALDH1A1 (0.44) HPGDALDH1A1NPC1HTTTSHR
SCHEMBL9888733 0.85 PIK3C3 (0.38) ALDH1A1NPC1HTTKDM4ERAB9A
SCHEMBL9888615 0.84 PANK3 (0.41) HPGDALDH1A1HTTKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859768-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-10-14 US disclosed
US-20120142732-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-06-07 US disclosed
WO-2012021615-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142732-A1 HETEROARYLS AND USES THEREOF PIK3R4, PIK3C2B, PIK3R1 HPGD 3886/4885ALDH1A1 1905/4885CYP1A2 1443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.